Scarica l'app Stockscreener
54.70
0.81%
-0.2577
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CYTK Giù?
Forum
Previsione
Frazionamento azionario
Cytokinetics Inc Borsa (CYTK) Ultime notizie
Cytokinetics, Inc. Experiences Evaluation Revision Amidst Evolving Market Dynamics - Markets Mojo
Lost Money on Cytokinetics, Incorporated (CYTK)? Contact Levi & Korsinsky to Join Class Action Before November 17, 2025 - ACCESS Newswire
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - GlobeNewswire Inc.
Cytokinetics Incorporated (CYTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, - GlobeNewswire
Insider Sell Alert: Kaye Edward M. MD Sells Shares of Cytokineti - GuruFocus
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm - MarketScreener
Cytokinetics, Incorporated Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCYTK - MarketScreener
Shareholders SueWallSt in New Class Action Against Cytokinetics, IncorporatedAct Now - Nasdaq
Should I hold or sell Cytokinetics Incorporated stock in 20252025 Market WrapUp & Weekly Chart Analysis and Guides - newser.com
Why Cytokinetics Incorporated (KK3A) stock appears on watchlistsQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Stock Traders Purchase High Volume of Cytokinetics Call Options (NASDAQ:CYTK) - Defense World
CYTK Stockholders With Large Losses Should Contact Robbins LLP For Information About The Cytokinetics, Inc. Securities Fraud Class Action - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Cytokinetics, Incorporated (CYTK) Investors of November 17, 2025 Deadline - ACCESS Newswire
HC Wainwright & Co. Reiterates Cytokinetics (CYTK) Buy Recommendation - Nasdaq
Shareholders who lost money in shares of Cytokinetics, - GlobeNewswire
How Cytokinetics Incorporated stock benefits from tech adoptionJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
Cytokinetics, Incorporated Securities Lawsuit Investigation - Claim Depot
Cytokinetics (CYTK) Receives Reiterated 'Buy' Rating with $120 T - GuruFocus
Cytokinetics (NASDAQ:CYTK) Earns "Buy" Rating from HC Wainwright - MarketBeat
Published on: 2025-09-29 10:40:49 - newser.com
Investors Buy Large Volume of Cytokinetics Call Options (NASDAQ:CYTK) - MarketBeat
Can Cytokinetics Incorporated (KK3A) stock sustain breakout momentumJuly 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Strategies to average down on Cytokinetics IncorporatedJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Should I buy Cytokinetics Incorporated (KK3A) stock before earnings seasonGDP Growth & Safe Entry Trade Reports - newser.com
Cytokinetics (CYTK) Reveals Promising Aficamten Data at Heart Fa - GuruFocus
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Cytokinetics presents new data related to aficamten - MarketScreener
Cytokinetics Announces Positive Data on Aficamten's Impact on Exercise Capacity and Long-Term Efficacy at HFSA Annual Scientific Meeting 2025 - Quiver Quantitative
Cytokinetics Presents New Data Related To Aficamten - TradingView
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 - Yahoo Finance
Cytokinetics Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming DeadlinesCYTK - PR Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel - Caledonian Record
What drives Cytokinetics Incorporated KK3A stock priceMarket Sentiment Indicators & Small Entry Cost Trading - earlytimes.in
Can Cytokinetics Incorporated (KK3A) stock expand revenue streamsRate Cut & Daily Profit Maximizing Trade Tips - newser.com
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, I - PR Newswire
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) InvestorsContact Levi & Korsinsky Before November 17, 2025 - ACCESS Newswire
Class Action Filed Against Cytokinetics, Incorporated (CYTK)November 17, 2025 Deadline to JoinContact Levi & Korsinsky - Morningstar
Published on: 2025-09-26 01:51:19 - newser.com
November 17, 2025 Deadline Approaching: Join Class Action Against Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky - Newsfile
Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):